By Michael Gwarisa Following the delivery of injectable Pre-Exposure Prophylaxis (PrEP) doses, Zimbabwe through the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) consortium, has launched stage 2 of the CATALYST study, introducing the newly approved injectable PrEP. The study is funded by funded by PEPFER through USAID. The CATALYST study was initially launched in 2023 where two PrEP methods — tenofovir-based oral pills and the dapivirine ring (PrEP ring) — were offered. The CATALYST sites remain the same six sites where stage 1 was conducted. These include…
Read MoreZimbabwe Launches Stage 2 of CATALYST Study, Adding Injectable PrEP to HIV Prevention Options for Participants
